Suzanne D. DeBrosse

1.0k total citations
17 papers, 422 citations indexed

About

Suzanne D. DeBrosse is a scholar working on Molecular Biology, Clinical Biochemistry and Genetics. According to data from OpenAlex, Suzanne D. DeBrosse has authored 17 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Clinical Biochemistry and 6 papers in Genetics. Recurrent topics in Suzanne D. DeBrosse's work include Metabolism and Genetic Disorders (9 papers), Mitochondrial Function and Pathology (5 papers) and Epilepsy research and treatment (3 papers). Suzanne D. DeBrosse is often cited by papers focused on Metabolism and Genetic Disorders (9 papers), Mitochondrial Function and Pathology (5 papers) and Epilepsy research and treatment (3 papers). Suzanne D. DeBrosse collaborates with scholars based in United States, Canada and Netherlands. Suzanne D. DeBrosse's co-authors include Douglas S. Kerr, Shulin Zhang, Kazuki Okajima, Christine Schmotzer, Ghunwa Nakouzi, Gyula Acsádi, Kathryn J. Swoboda, Kenneth Silver, Jirair K. Bedoyan and Xiaohong Zhang and has published in prestigious journals such as Annals of Neurology, Eye and Molecular Genetics and Metabolism.

In The Last Decade

Suzanne D. DeBrosse

15 papers receiving 418 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Suzanne D. DeBrosse United States 12 246 182 115 55 55 17 422
Léna Damaj France 11 186 0.8× 108 0.6× 109 0.9× 71 1.3× 38 0.7× 19 479
Kathrin Jeltsch Germany 9 160 0.7× 198 1.1× 84 0.7× 50 0.9× 17 0.3× 18 387
Tessa Wassenberg Netherlands 11 112 0.5× 156 0.9× 61 0.5× 28 0.5× 27 0.5× 19 372
Anna Wedell Sweden 11 321 1.3× 220 1.2× 142 1.2× 46 0.8× 40 0.7× 28 498
Christine Makowski Germany 10 229 0.9× 143 0.8× 51 0.4× 51 0.9× 116 2.1× 18 480
Heiko Brennenstuhl Germany 11 180 0.7× 99 0.5× 74 0.6× 30 0.5× 12 0.2× 25 315
Stephanie Kleinle Germany 17 587 2.4× 292 1.6× 115 1.0× 38 0.7× 31 0.6× 27 772
Thatjana Gardeitchik Netherlands 13 233 0.9× 105 0.6× 162 1.4× 78 1.4× 11 0.2× 19 419
Hiroko Shimbo Japan 12 192 0.8× 101 0.6× 73 0.6× 33 0.6× 22 0.4× 33 315
Dawn Cordeiro Canada 10 200 0.8× 173 1.0× 233 2.0× 61 1.1× 145 2.6× 15 484

Countries citing papers authored by Suzanne D. DeBrosse

Since Specialization
Citations

This map shows the geographic impact of Suzanne D. DeBrosse's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Suzanne D. DeBrosse with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Suzanne D. DeBrosse more than expected).

Fields of papers citing papers by Suzanne D. DeBrosse

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Suzanne D. DeBrosse. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Suzanne D. DeBrosse. The network helps show where Suzanne D. DeBrosse may publish in the future.

Co-authorship network of co-authors of Suzanne D. DeBrosse

This figure shows the co-authorship network connecting the top 25 collaborators of Suzanne D. DeBrosse. A scholar is included among the top collaborators of Suzanne D. DeBrosse based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Suzanne D. DeBrosse. Suzanne D. DeBrosse is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
DeBrosse, Suzanne D., et al.. (2022). Case Report: 2-Year-old With Wilms Tumors, Familial Heterozygous DIS3L2 Mutation, and Cutis Marmorata Telangiectatica Congenita. Journal of Pediatric Hematology/Oncology. 45(1). e128–e130.
2.
DeBrosse, Suzanne D., et al.. (2020). Kleefstra syndrome: Impact on parents. Disability and health journal. 14(2). 101018–101018. 5 indexed citations
4.
DeBrosse, Suzanne D., Steven Strausbaugh, Moira L. Aitken, et al.. (2019). The expanding phenotype of OFD1‐related disorders: Hemizygous loss‐of‐function variants in three patients with primary ciliary dyskinesia. Molecular Genetics & Genomic Medicine. 7(9). e911–e911. 39 indexed citations
5.
Park, Jun, Michael W. Devereaux, Hesham Abboud, et al.. (2019). Electroencephalography and Epilepsy Course at UH Cleveland Medical Center, Cleveland, Ohio, United States. 8(1). 2–10.
6.
Bedoyan, Jirair K., Leah Hecht, Shulin Zhang, et al.. (2019). A novel null mutation in the pyruvate dehydrogenase phosphatase catalytic subunit gene (PDP1) causing pyruvate dehydrogenase complex deficiency. JIMD Reports. 48(1). 26–35. 11 indexed citations
7.
Zaman, Tariq, Ingo Helbig, Ivana Babič Božović, et al.. (2018). Mutations inSCN3Acause early infantile epileptic encephalopathy. Annals of Neurology. 83(4). 703–717. 68 indexed citations
8.
DeBrosse, Suzanne D., et al.. (2017). Inborn Errors of Metabolism with Acidosis. Pediatric Clinics of North America. 65(2). 209–230. 14 indexed citations
9.
Silver, Kenneth, et al.. (2017). Fever-Induced Paroxysmal Weakness and Encephalopathy, a New Phenotype of ATP1A3 Mutation. Pediatric Neurology. 73. 101–105. 47 indexed citations
10.
Bedoyan, Jirair K., Samuel Yang, Sacha Ferdinandusse, et al.. (2017). Lethal neonatal case and review of primary short-chain enoyl-CoA hydratase (SCEH) deficiency associated with secondary lymphocyte pyruvate dehydrogenase complex (PDC) deficiency. Molecular Genetics and Metabolism. 120(4). 342–349. 33 indexed citations
11.
Huang, Xiaoping, Jirair K. Bedoyan, Didem Demirbas, et al.. (2016). Succinyl-CoA synthetase ( SUCLA2 ) deficiency in two siblings with impaired activity of other mitochondrial oxidative enzymes in skeletal muscle without mitochondrial DNA depletion. Molecular Genetics and Metabolism. 120(3). 213–222. 21 indexed citations
12.
Appleby, Brian S., Mark L. Cohen, Suzanne D. DeBrosse, et al.. (2016). Clinical and imaging characteristics of late onset mitochondrial membrane protein-associated neurodegeneration (MPAN). Neurocase. 22(5). 476–483. 13 indexed citations
13.
Splitt, Miranda, Venkateswaran Ramesh, Suzanne D. DeBrosse, et al.. (2016). FHF1 (FGF12) epileptic encephalopathy. Neurology Genetics. 2(6). e115–e115. 29 indexed citations
14.
Stöckler‐Ipsiroglu, Sylvia, Roberta Battini, Suzanne D. DeBrosse, et al.. (2015). Arginine:glycine amidinotransferase (AGAT) deficiency: Clinical features and long term outcomes in 16 patients diagnosed worldwide. Molecular Genetics and Metabolism. 116(4). 252–259. 45 indexed citations
15.
DeBrosse, Suzanne D. & Sumit Parikh. (2012). Neurologic Disorders Due to Mitochondrial DNA Mutations. Seminars in Pediatric Neurology. 19(4). 194–202. 10 indexed citations
16.
DeBrosse, Suzanne D., Kazuki Okajima, Shulin Zhang, et al.. (2012). Spectrum of neurological and survival outcomes in pyruvate dehydrogenase complex (PDC) deficiency: Lack of correlation with genotype. Molecular Genetics and Metabolism. 107(3). 394–402. 73 indexed citations
17.
DeBrosse, Suzanne D., et al.. (2007). Dynamic properties of eye movements in mitochondrial chronic progressive external ophthalmoplegia. Eye. 23(2). 382–388. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026